Polaris Capital Management »

Biosante Pharmaceuticals shares owned by Polaris Capital Management

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Polaris Capital Management from 13F filings

Historical chart of Polaris Capital Management investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Polaris Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Polaris Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $766k 9.7k 78.94
2025-09-30 $889k 9.7k 91.60

More positions owned by Polaris Capital Management

Popular CommonStock (BPOP)
Jazz Pharmaceuticals CommonStock (JAZZ)
Linde CommonStock (LIN)
Smurfit Westrock CommonStock (SW)
United Therapeutics Corp CommonStock (UTHR)
MKS CommonStock (MKSI)
Cvs Health Corp CommonStock (CVS)
Jpmorgan Chase & Co CommonStock (JPM)
Lantheus Holdings CommonStock (LNTH)
Slm Corp CommonStock (SLM)
Arrow Electronics CommonStock (ARW)
Gilead Sciences CommonStock (GILD)
Webster Financial Corp - Ct CommonStock (WBS)
International Bancshares Corp CommonStock
General Dynamics Corp. CommonStock (GD)

View all positions for Polaris Capital Management

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
State Street Corporation
Global Alpha Capital Management
Citadel Advisors
Dimensional Fund Advisors
Geode Capital Management
Deep Track Capital
Point72 Asset Management
Nuveen
Goldman Sachs Group
Arrowstreet Capital, Limited Partnership
William Blair Investment Management
Rubric Capital Management
Soleus Capital Management

View all funds holding Biosante Pharmaceuticals